The therapeutic plasma exchange global market report 2024from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Therapeutic Plasma Exchange Market, 2024report by The Business Research Company
offers comprehensive insights into the current state of the market and
highlights future growth opportunities.
Market Size - The therapeutic plasma exchange market size has grown strongly in
recent years. It will grow from $1.35 billion in 2023 to $1.47 billion in 2024
at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic
period can be attributed to the emergence of immunological diseases, increasing
technological advancements, increased awareness and education, expanded
indications, and improved understanding of the pathophysiology.
The therapeutic plasma exchange market size is expected to see strong growth in
the next few years. It will grow to $2.12 billion in 2028 at a compound annual
growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed
to the rising geriatric population, clinical evidence and guidelines,
regulatory environment, hospital infrastructure and healthcare investments,
healthcare expenditure, and reimbursement policies. Major trends in the forecast
period include personalized therapies, integration of automation, collaborative
initiatives, and telemedicine integration.
Order your report now for swift delivery @ https://www.thebusinessresearchcompany.com/report/therapeutic-plasma-exchange-global-market-report
Scope Of Therapeutic Plasma Exchange MarketThe Business Research Company's
reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market's historical
performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market
landscape.
4. Key Segments: Breakdown of the market into its primary segments and their
respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and
geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting
the market.
Therapeutic Plasma Exchange Market Overview
Market Drivers -The high prevalence of hematological disorders is expected to
propel the growth of the therapeutic plasma exchange market going forward.
Hematological disorders, also known as blood disorders, refer to medical
conditions that affect the blood and blood-forming tissues, including the bone
marrow, lymph nodes, and spleen. Hematological disorders are rising due to
factors including genetic predispositions, environmental influences, and
lifestyle changes. Therapeutic plasma exchange (TPE) is utilized in
hematological disorders to remove pathogenic substances from the plasma, such
as autoantibodies in autoimmune hemolytic anemia or immune complexes in
thrombotic thrombocytopenic purpura, thereby mitigating disease severity and
improving patient outcomes. For instance, in August 2023, according to the
Leukemia and Lymphoma Society, a US-based professional organization, the number
of projected myeloma diagnoses is expected to rise by around 2.3% from 2021 to
2023, increasing from 34,920 to 35,730, respectively. Therefore, the high
prevalence of hematological disorders is driving the growth of the therapeutic
plasma exchange market.
Market Trends - Major companies operating in the therapeutic plasma exchange
market are focused on developing technologically advanced products, such as
automated plasma exchange systems, that can improve treatment accuracy,
increase workflow efficiency, and simplify therapy setup and delivery.
Automated plasma exchange systems are medical devices designed to perform
therapeutic plasma exchange (TPE) procedures in a controlled and efficient
manner. For instance, in May 2021, Baxter International Inc., a US-based
healthcare company, launched the PrisMax 2 system, an automated plasma exchange
system designed to advance critical care delivery for patients and hospitals by
removing harmful substances from a patient's blood. This new system addresses
key challenges faced in the intensive care unit (ICU), offering operational
simplicity, smart efficiencies, and data-driven insights. The PrisMax 2 system
simplifies the complexities of delivering continuous renal replacement therapy
(CRRT) and other extracorporeal therapies, enhancing therapy management from
setup to delivery.
The therapeutic plasma exchange market covered in this report is segmented –
1) By Type: Therapeutic Plasma Exchange (TPE), Double Filtered Plasmapheresis
(DFPP)
2) By Indication: Neurological Disorders, Hematological Disorders, Renal
Disorders, Metabolic Disorders, Other Indications
3) By Technology: Centrifugation, Membrane Separation
4) By End User: Blood Collection Centers, Hospitals And Clinics, Transfusion
Centers, Other End Users
Get an inside scoop of the therapeutic plasma exchange market, Request now for
Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=15683&type=smp
Regional Insights - North America was the largest region in the therapeutic
plasma exchange market in 2023. Asia-Pacific is expected to be the
fastest-growing region in the forecast period. The regions covered in the
therapeutic plasma exchange market report are Asia-Pacific, Western Europe,
Eastern Europe, North America, South America, Middle East, Africa.
Key Companies - Major companies operating in the therapeutic plasma exchange
market are Medica S.p.A., Fresenius SE and Co. KGaA, Medtronic Plc., Asahi
Kasei Corporation, Toray Industries Inc., Baxter International Inc., B Braun
Melsungen AG, Terumo Corporation, Kaneka Corporation, Charles River
Laboratories, Octapharma AG, Spectral Medical Inc., Nikkiso Co. Ltd.,
Haemonetics Corporation, Miltenyi Biotec Technology And Trading Co. Ltd.,
Macopharma SA, Cerus Corporation, Apellis Pharmaceuticals Inc., ImmunoTek Bio
Centers LLC, CytoSorbents Corporation, Kawasumi Laboratories America Inc.,
Japan Medical Supply Co. Ltd.
Table of Contents 1. Executive Summary2. Therapeutic Plasma Exchange Market
Report Structure3. Therapeutic Plasma Exchange Market Trends And Strategies4.
Therapeutic Plasma Exchange Market – Macro Economic Scenario5. Therapeutic
Plasma Exchange Market Size And Growth…..27. Therapeutic Plasma Exchange Market
Competitor Landscape And Company Profiles28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model:
https://www.thebusinessresearchcompany.com/global-market-model
No comments:
Post a Comment